Dropless Pars Plana Vitrectomy Study
Condition: Rhegmatogenous Retinal Detachment Interventions: Procedure: Pars plana vitrectomy; Drug: Triamcinolone Acetonide 40mg/mL; Drug: Moxifloxacin 0.5% or Polymyxin/Trimethoprim if patient is allergic to moxifloxacin; Drug: Prednisolone 1%; Drug: Atropine 1% Sponsor: Massachusetts Eye and Ear Infirmary Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials